Nachrichten zur GW Pharmaceuticals PLC (ADRs) Aktie

ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

Todays Daily Dose brings you news about the progress in Ailerons phase Ib clinical study of ALRN-6924, CymaBays positive results…

Why GW Pharmaceuticals Stock Is Up Today

The FDA approved a new indication for the companys top-selling product....…

GW Pharmas stock rallies after its cannabinoid drug gets a new FDA approval

Shares of GW Pharmaceuticals rallied 5.0% in trading on Monday after the drugmaker said its cannabinoid drug Epidiolex had…

How GW Pharma Is Expanding Its Cannabidiol Seizure Treatment

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should Investors Buy GW Pharma Stock Right Now?

Wall Street analysts think this stock could double. Are they right?...…

The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 30) read more...…

The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings

Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks. read…

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Second Quarter Ending June 30th, 2020 and Host Conference Call on August 6th, 2020

LONDON and CARLSBAD, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the…

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

Whats the choice between these U.K and U.S. biotech-cannabis companies?...…

GW Pharmaceuticals stock slips after Stifel analyst backs off long-standing bullish view

Shares of GW Pharmaceuticals PLC fell 0.4% in premarket trading, after Stifel Nicolaus analyst Paul Matteis downgraded the maker…

Could GW Pharmaceuticals Be a Millionaire-Maker Stock?

Heres why a small investment in GW Pharmaceuticals can go a long way....…

New Reasons For GW Pharmaceuticals To Ride High

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Cannabis Play: GW Pharmaceuticals vs. Innovative Industrial Properties

Heres how the leading cannabinoid-focused biotech stacks up against the top cannabis-focused REIT....…

Is GW Pharmaceuticals Stock a Buy?

Its already up 20% this year....…

GW Pharma updates plan to commercialize nabiximols in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Where Will GW Pharmaceuticals Be in 1 Year?

Heres why this shares of this cannabinoid drug company will keep soaring within the next year....…

Better Buy: GW Pharmaceuticals vs. Cara Therapeutics

Both of these biotechs could have big catalysts on the way....…

GW Pharma Makes Big Regulatory Step for Cannabidiol in UK

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug

GWs cannabis-based medicine rescheduled following approval by the European Medicines Agency (EMA) and an independent assessment by the Advisory Council…

1 Cannabis Stock Beating the Market This Year

GW Pharma has been performing well recently, but is this cannabis stock a buy?...…

GW Pharmaceuticals Is Picking Up Steam in 2020

The maker of Epidiolex is showing positive momentum after a tremendous first quarter....…

GW Pharmaceuticals to Host Virtual Investor Event on Its Nabiximols U.S. Development Program and Market Opportunity

LONDON and CARLSBAD, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW or the…

The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings

Heres a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week…

How GW Pharmaceuticals Hit a Home Run in Q1

Nearly everything that could go right went right for the cannabis-focused drugmaker....…

GW Pharmaceuticals PLC (GWPH) Q1 2020 Earnings Call Transcript

GWPH earnings call for the period ending March 31, 2020....…

GW Pharmaceuticals PLC (GWPH) CEO Justin Gover on Q1 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Marijuana Stock GW Pharmaceuticals Delivers Rapid Growth In Q1

Demand for the marijuana drug developers treatment for epilepsy caused shares to skyrocket last quarter....…

Aurora Cannabis and Tilray set to detail hoarding of marijuana during COVID-19

Several of the largest cannabis companies are set to report earnings this week, with Tilray Inc. and GW Pharmaceuticals…

Is It Time to Get in on GW Pharmaceuticals While the Price Is Right-

It isnt turning a profit yet, but its revenue is about to jump....…

GW Pharmaceuticals Q1 Results Will Provide Important Markers For The Coming Year

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020

LONDON and CARLSBAD, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the First Quarter Ending March 31st, 2020 and Host Conference Call on May 11th, 2020

CARLSBAD, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, "GW or "the Company), a…

The DEA Has Descheduled Prescription CBD for Severe Epilepsy

Marketing Epidiolex is about to get a lot easier for GW Pharmaceuticals....…

GW Pharmas Epidiolex descheduled by DEA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance

- Descheduling will enable prescribing free of the previous Schedule V requirements -...…

FDA accepts GW Pharma application for expanded use of Epidiolex

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex

PDUFA date of July 31, 2020 PDUFA date of July 31, 2020...…

2 Excessive Dips Provide A Very Good Buying Opportunity: GW Pharmaceuticals

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is This the Most Undervalued Cannabis Stock-

Epidiolexs growing sales arent enough to help GW Pharma beat the market....…

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

These cannabinoid-based drug developers offer different risk/reward profiles....…

Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today

A rebounding stock market lifted all three of these biotech stocks....…

GW Pharma submits Type II variation application for Epidyolex in Europe

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)

LONDON, March 13, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW, "the Company or "the Group),…